No Data
Indaptus Therapeutics Announces Securities Purchase Agreements and Private Placement for $2.135 Million
Indaptus Therapeutics Announces $2.135M Registered Direct Offering And Private Placement, Issuing Shares And Warrants At $1.175 Per Unit, With Closing Expected November 25, 2024
Express News | Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Press Release: Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Maxim Group Maintains Indaptus Therapeutics(INDP.US) With Buy Rating, Cuts Target Price to $5
Express News | Indaptus Therapeutics Inc : Maxim Group Cuts Target Price to $5 From $8
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
